These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


631 related items for PubMed ID: 27267628

  • 21. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
    Yu J, Sun L, Zhou J, Gao L, Nan L, Zhao S, Peng T, Han L, Wang J, Lu W, Zhang L, Wang Y, Yan Z, Yu L.
    Bioconjug Chem; 2017 Nov 15; 28(11):2823-2831. PubMed ID: 28968068
    [Abstract] [Full Text] [Related]

  • 22. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
    Feng X, Yao J, Gao X, Jing Y, Kang T, Jiang D, Jiang T, Feng J, Zhu Q, Jiang X, Chen J.
    ACS Appl Mater Interfaces; 2015 Dec 23; 7(50):27885-99. PubMed ID: 26619329
    [Abstract] [Full Text] [Related]

  • 23. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.
    J Control Release; 2010 Apr 02; 143(1):136-42. PubMed ID: 20056123
    [Abstract] [Full Text] [Related]

  • 24. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
    Zhan C, Wei X, Qian J, Feng L, Zhu J, Lu W.
    J Control Release; 2012 Jun 28; 160(3):630-6. PubMed ID: 22410115
    [Abstract] [Full Text] [Related]

  • 25. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH, Lu Q, Xie J, Fang C, Chen HZ.
    Biomaterials; 2010 Mar 28; 31(8):2278-92. PubMed ID: 20053444
    [Abstract] [Full Text] [Related]

  • 26. UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma.
    Zhang B, Zhang Y, Liao Z, Jiang T, Zhao J, Tuo Y, She X, Shen S, Chen J, Zhang Q, Jiang X, Hu Y, Pang Z.
    Biomaterials; 2015 Jan 28; 36():98-109. PubMed ID: 25443789
    [Abstract] [Full Text] [Related]

  • 27. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
    Wu J, Zhao J, Zhang B, Qian Y, Gao H, Yu Y, Wei Y, Yang Z, Jiang X, Pang Z.
    Int J Nanomedicine; 2014 Jan 28; 9():5261-71. PubMed ID: 25419130
    [Abstract] [Full Text] [Related]

  • 28. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X.
    Biomaterials; 2011 Jun 28; 32(18):4293-305. PubMed ID: 21427009
    [Abstract] [Full Text] [Related]

  • 29. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel.
    Ma Y, Li R, Dong Y, You C, Huang S, Li X, Wang F, Zhang Y.
    Int J Nanomedicine; 2021 Jun 28; 16():789-802. PubMed ID: 33568906
    [Abstract] [Full Text] [Related]

  • 30. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y, Ran R, Chen J, Kuang Q, Tang J, Mei L, Zhang Q, Gao H, Zhang Z, He Q.
    Biomaterials; 2014 Jun 28; 35(17):4835-47. PubMed ID: 24651033
    [Abstract] [Full Text] [Related]

  • 31. Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment.
    Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, Feng C, Xie Y, Sha X, Fang X.
    Biomaterials; 2014 Jan 28; 35(1):518-29. PubMed ID: 24125772
    [Abstract] [Full Text] [Related]

  • 32. Glioma-Targeted Drug Delivery Enabled by a Multifunctional Peptide.
    Zhang M, Chen X, Ying M, Gao J, Zhan C, Lu W.
    Bioconjug Chem; 2017 Mar 15; 28(3):775-781. PubMed ID: 27966896
    [Abstract] [Full Text] [Related]

  • 33. Tumor Microenvironment and Angiogenic Blood Vessels Dual-Targeting for Enhanced Anti-Glioma Therapy.
    Hu Q, Kang T, Feng J, Zhu Q, Jiang T, Yao J, Jiang X, Chen J.
    ACS Appl Mater Interfaces; 2016 Sep 14; 8(36):23568-79. PubMed ID: 27580101
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
    Gao H, Xiong Y, Zhang S, Yang Z, Cao S, Jiang X.
    Mol Pharm; 2014 Mar 03; 11(3):1042-52. PubMed ID: 24521297
    [Abstract] [Full Text] [Related]

  • 37. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H, Yang Z, Zhang S, Cao S, Pang Z, Yang X, Jiang X.
    J Control Release; 2013 Dec 28; 172(3):921-8. PubMed ID: 24120853
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH, Liu YR, Luan X, Liu HJ, Gao YG, Wu H, Fang C, Chen HZ.
    Bioconjug Chem; 2015 Aug 19; 26(8):1702-12. PubMed ID: 26076081
    [Abstract] [Full Text] [Related]

  • 40. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M, Danhier F, Bastiancich C, Joudiou N, Ganipineni LP, Tsakiris N, Gallez B, Rieux AD, Jankovski A, Bianco J, Préat V.
    Int J Pharm; 2018 Sep 05; 548(1):522-529. PubMed ID: 30017818
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.